NeuroNetwork for Emerging Therapies at Michigan Medicine in Ann Arbor, MI is a leading brand in the field of neurology and emerging therapies. Specializing in the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, the brand offers a comprehensive range of services to improve the quality of life for patients. The Pranger ALS Clinic at Michigan Medicine provides expert diagnostic services and compassionate care throughout the entire disease course of ALS.

The clinic also treats other forms of motor neuron diseases such as Primary Lateral Sclerosis (PLS), Primary Muscular Atrophy (PMA), Progressive Bulbar Palsy (PBP), and Kennedy’s Disease. With a thorough patient history and neurological examination, the clinic assesses ALS and conducts diagnostic testing including MRI and EMG. Three treatments are available to lengthen life, including medication, non-invasive ventilation, and diet and nutritional therapy.

NeuroNetwork for Emerging Therapies is committed to advancing research in the field, offering clinical trials and observational studies for patients to participate in. Patients also benefit from a wide range of support services and resources, ensuring comprehensive care for the mind and body. With a team of experienced faculty and staff, NeuroNetwork for Emerging Therapies is dedicated to providing the highest level of care and support to individuals living with motor neuron diseases